Stock Forecast
As of Sat Feb 13 2021 00:00:03 GMT+0000 (Coordinated Universal Time) shares of PHAS PhaseBio Pharmaceuticals -2.82 percentage change in price since the previous day's close. Around 364793 of 29365000 changed hand on the market. The Stock opened at 5.08 with high and low of 4.71 and 5.08 respectively. The price/earnings ratio is: - and earning per share is -2.75. The stock quoted a 52 week high and low of 2.6 and 6.85 respectively.
BOSTON (AI Forecast Terminal) Mon, Feb 15, '21 AI Forecast today took the forecast actions: In the context of stock price realization of PHAS PhaseBio Pharmaceuticals is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+7) for PHAS PhaseBio Pharmaceuticals as below:
PHAS PhaseBio Pharmaceuticals Credit Rating Overview
We rerate PHAS PhaseBio Pharmaceuticals because of no indications exist that private equity, management, or shareholders may reduce or prevent the maintenance of capital. We use econometric methods for period (n+7) simulate with Sustainability Pearson Correlation. Reference code is: 1037. Beta DRL value REG 29 Rational Demand Factor LD 6186.0834. Asset divestitures. We do not include asset sales as a source of liquidity unless they are contracted and proceeds will be received in the time period being measured under the liquidity descriptor (even when the disposed assets are reported under discontinued operations in a company's financial statements). Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.
Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for PHAS PhaseBio Pharmaceuticals as below:
Frequently Asked Questions
Q: What is PHAS PhaseBio Pharmaceuticals stock symbol?A: PHAS PhaseBio Pharmaceuticals stock referred as NASDAQ:PHAS
Q: What is PHAS PhaseBio Pharmaceuticals stock price?
A: On share of PHAS PhaseBio Pharmaceuticals stock can currently be purchased for approximately 4.83
Q: Do analysts recommend investors buy shares of PHAS PhaseBio Pharmaceuticals ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for PHAS PhaseBio Pharmaceuticals at daily forecast section
Q: What is the earning per share of PHAS PhaseBio Pharmaceuticals ?
A: The earning per share of PHAS PhaseBio Pharmaceuticals is -2.75
Q: What is the market capitalization of PHAS PhaseBio Pharmaceuticals ?
A: The market capitalization of PHAS PhaseBio Pharmaceuticals is 141832947
